- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
3M/Cemax-Icon deal bears fruit at AHRA show
PACS firms 3M and Cemax-Icon displayed one of the first resultsof their new relationship at this month's American HealthcareRadiology Administrators meeting in Nashville. The companies introducedCemax-Icon ArchiveManager 2.0, a new software product that
PACS firms 3M and Cemax-Icon displayed one of the first resultsof their new relationship at this month's American HealthcareRadiology Administrators meeting in Nashville. The companies introducedCemax-Icon ArchiveManager 2.0, a new software product that useshierarchical storage management (HSM) to manage images for archivingmedia, including optical jukeboxes, tape jukeboxes and RAID (redundantarray of inexpensive disks) systems.
3M provided the software and data-storage media for ArchiveManagerwhile Cemax-Icon developed the application interface. Cemax-Iconwill market the software, which is compatible with its line ofPACS products and which supports the DICOM 3.0 and HL7 standards.3M made an equity investment in Cemax-Icon in June (SCAN 6/21/95).
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
